Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;80(2):249-260.
doi: 10.1007/s13105-023-01002-x. Epub 2023 Dec 30.

N6-methyladenosine in myeloid cells: a novel regulatory factor for inflammation-related diseases

Jin Pang  1 , Tong-Dong Kuang  1 , Xin-Yuan Yu  1 , Petr Novák  1 , Yuan Long  2 , Min Liu  2 , Wei-Qian Deng  2 , Xiao Zhu  3 , Kai Yin  4
Affiliations
Review

N6-methyladenosine in myeloid cells: a novel regulatory factor for inflammation-related diseases

Jin Pang et al. J Physiol Biochem. 2024 May.

Abstract

N6-methyladenosine (m6A) is one of the most abundant epitranscriptomic modifications on eukaryotic mRNA. Evidence has highlighted that m6A is altered in response to inflammation-related factors and it is closely associated with various inflammation-related diseases. Multiple subpopulations of myeloid cells, such as macrophages, dendritic cells, and granulocytes, are crucial for the regulating of immune process in inflammation-related diseases. Recent studies have revealed that m6A plays an important regulatory role in the functional of multiple myeloid cells. In this review, we comprehensively summarize the function of m6A modification in myeloid cells from the perspective of myeloid cell production, activation, polarization, and migration. Furthermore, we discuss how m6A-mediated myeloid cell function affects the progression of inflammation-related diseases, including autoimmune diseases, chronic metabolic diseases, and malignant tumors. Finally, we discuss the challenges encountered in the study of m6A in myeloid cells, intended to provide a new direction for the study of the pathogenesis of inflammation-related diseases.

Keywords: Inflammation-related diseases; Myeloid cells; N6-methyladenosine.

PubMed Disclaimer

References

    1. Andersen V et al (2020) Caesarean delivery and risk of chronic inflammatory diseases (inflammatory bowel disease, rheumatoid arthritis, coeliac disease, and diabetes mellitus): a population based registry study of 2,699,479 births in Denmark during 1973–2016. Clin Epidemiol 12:287–293 - PubMed - PMC - DOI
    1. Atri C, Guerfali FZ, Laouini D (2018) Role of human macrophage polarization in inflammation during infectious diseases. Int J Mol Sci 19(6):1801. https://doi.org/10.3390/ijms19061801
    1. Bokar JA et al (1997) Purification and cDNA cloning of the AdoMet-binding subunit of the human mRNA (N6-adenosine)-methyltransferase. RNA 3(11):1233–1247 - PubMed - PMC
    1. Bowers E et al (2018) Granulocyte-derived TNFalpha promotes vascular and hematopoietic regeneration in the bone marrow. Nat Med 24(1):95–102 - PubMed - DOI
    1. Caiado F, Pietras EM, Manz MG (2021) Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection. J Exp Med 218(7):e20201541. https://doi.org/10.1084/jem.20201541

LinkOut - more resources